Cargando…
Comparison of exenatide alone or combined with metformin versus metformin in the treatment of polycystic ovaries: a systematic review and meta-analysis
BACKGROUND: Polycystic ovary syndrome (PCOS) is the most common cause of anovulatory infertility in women of childbearing age. Randomized controlled trials (RCTs) have reported that exenatide and metformin are effective in the treatment of PCOS. In this meta-analysis, we aimed to compare the effecti...
Autores principales: | Hu, Yan, Song, Xiangxin, Hamiti, Shaila, Ma, Yanyong, Yusufu, Mainu, Wang, Xing, Zhang, Kaidi, Guo, Yanying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10652559/ https://www.ncbi.nlm.nih.gov/pubmed/37974132 http://dx.doi.org/10.1186/s12902-023-01497-x |
Ejemplares similares
-
Short-term combined treatment with exenatide and metformin for overweight/obese women with polycystic ovary syndrome
por: Ma, Rui-Lin, et al.
Publicado: (2021) -
Metformin combined with spironolactone vs. metformin alone in polycystic ovary syndrome: a meta-analysis
por: Zeng, Huamin, et al.
Publicado: (2023) -
Acupuncture combined with metformin versus metformin alone to improve pregnancy rate in polycystic ovary syndrome: A systematic review and meta-analysis
por: Chen, Xin, et al.
Publicado: (2022) -
The Effectiveness and Safety of Exenatide Versus Metformin in Patients with Polycystic Ovary Syndrome: A Meta-Analysis of Randomized Controlled Trials
por: Ye, Zheng-Rong, et al.
Publicado: (2023) -
Effect of metformin versus metformin plus liraglutide on gonadal and metabolic profiles in overweight patients with polycystic ovary syndrome
por: Xing, Chuan, et al.
Publicado: (2022)